Dianthus Therapeutics snags $100m Series A
Dianthus Therapeutics, a biotechnology company, has raised $100 million in Series A financing.
Dianthus Therapeutics, a biotechnology company, has raised $100 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination